INCY vs TECH
Incyte vs Bio-Techne — AI-powered side-by-side comparison
| Metric | INCY | TECH |
|---|
| AI Score |
73
|
71
|
| Price |
$120.19
|
$72.42
|
| P/E Ratio |
14.78×
|
61.88×
|
| ROE |
24.9%
|
8.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
92.6%
|
65.8%
|
| Debt / Equity |
0.01×
|
0.13×
|
| Dividend Yield |
0.0%
|
0.4%
|
| RSI (14) |
51.8
|
63.6
|
| Beta |
0.769
|
1.277
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for INCY versus TECH.
INCY leads by 2 points.
INCY scores 73/100 (Buy) versus TECH at 71/100 (Buy).
INCY Committee View
100% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 29.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
- EPS growing 80.3% YoY — Growth
Bear Case
- MACD histogram negative -- bearish momentum — Technical
TECH Committee View
80% agreement
5 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
- Price structure (LH_LL) contradicts the uptrend -- mixed signals — Technical
- Weekly RSI at 75 -- overbought on the larger timeframe too — Technical